Westre, Bjørn; Giske, Anita; Guttormsen, Hilde; Sørbye, Sveinung; Skjeldestad, Finn Egil (Journal article; Tidsskriftartikkel; Peer reviewed, 2019-11-05)
Within 2021, Norway intends to complete implementation of HPV DNA-based primary screening for cervical cancer for women 34–69 years, while continue cytology-based screening for women 25–33 years. Over the recent years, the incidence of cervical cancer has increased by 30% among women younger than 40 years. In this subset of women, nearly 30% were diagnosed with a normal smear, as most recent smear, ...